Profile data is unavailable for this security.
About the company
Vaidya Sane Ayurved Laboratories Limited is an India-based company, which is engaged in research and development in ayurvedic medicines and the sale of ayurvedic medicines and products through its various franchises and own clinics. The Company is involved in providing ayurved medical professional services across its various clinics, including panchkarma and other ayurvedic treatments through the running of ayurvedic hospitals. The Company operates under brand Madhavbaug. It uses diagnostics, diet, physiotherapy and ayurveda to provide heart disease, diabetes, hypertension and obesity reversal treatments to its patients. The Company operates approximately 350 clinics across Maharashtra, Madhya Pradesh, Gujarat, Uttar Pradesh, Goa, Karnataka, Delhi, Punjab, Uttarakhand, West Bengal, and Chhattisgarh. The Company operates three cardiac prevention and rehabilitation hospitals in Khopoli, Kondhali, and Vishakhapatnam.
- Revenue in INR (TTM)993.31m
- Net income in INR19.80m
- Incorporated1999
- Employees636.00
- LocationVaidya Sane Ayurved Laboratories LtdShukrawar PethFl. 5, 1047, Shriram BhawanTHANE 400604IndiaIND
- Websitehttps://madhavbaug.org/clinic-hospital-locator/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Biofil Chemicals and Pharmaceuticals Ltd | 460.45m | 6.34m | 1.22bn | -- | 188.74 | -- | 119.22 | 2.65 | 0.3978 | 0.3978 | 28.96 | -- | -- | -- | -- | -- | -- | 2.74 | -- | 5.36 | 4.94 | 9.99 | 1.38 | 2.80 | -- | 7.63 | -- | -- | 33.29 | 11.60 | 26.55 | 8.02 | -56.15 | -- |
Ind Swift Ltd | 4.68bn | 401.08m | 1.23bn | 1.67k | 3.07 | -- | 1.87 | 0.2636 | 7.42 | 7.42 | 86.37 | -- | -- | -- | -- | -- | -- | -0.902 | -- | -- | 45.63 | 45.72 | 8.58 | -1.44 | -- | 0.1318 | -- | -- | 22.21 | 11.68 | -45.34 | 11.68 | 15.24 | -- |
Lasa Supergenerics Ltd | 1.05bn | -195.13m | 1.35bn | 77.00 | -- | -- | -- | 1.29 | -3.92 | -3.92 | 20.94 | -- | -- | -- | -- | 13,586,300.00 | -- | -3.86 | -- | -5.34 | 26.41 | 32.53 | -18.65 | -5.30 | -- | -4.49 | -- | -- | -19.47 | -9.26 | 43.73 | -- | -- | -- |
Vaidya Sane Ayurved Laboratories Ltd | 993.31m | 19.80m | 1.49bn | 636.00 | 84.90 | 2.67 | 28.94 | 1.50 | 1.66 | 1.66 | 78.54 | 52.89 | 1.58 | 6.83 | 15.11 | 1,561,813.00 | 3.16 | 4.83 | 4.02 | 7.49 | 74.12 | 70.91 | 2.00 | 2.53 | 2.11 | 5.49 | 0.0293 | -- | 0.1638 | 9.71 | -59.02 | 31.91 | 4.43 | -- |
Sotac Pharmaceuticals Ltd | 1.10bn | 37.21m | 1.52bn | 89.00 | 40.75 | -- | 21.34 | 1.38 | 3.37 | 3.37 | 99.70 | -- | -- | -- | -- | -- | -- | -- | -- | -- | 21.53 | -- | 3.38 | -- | -- | 2.75 | -- | -- | 79.07 | -- | -20.38 | -- | -- | -- |
Krebs Biochemicals And Industries Ltd | 527.29m | -195.67m | 1.73bn | 191.00 | -- | -- | -- | 3.28 | -9.08 | -9.08 | 24.47 | -- | -- | -- | -- | 2,760,691.00 | -- | -17.87 | -- | -27.01 | 85.82 | 15.68 | -37.11 | -58.62 | -- | -3.08 | -- | -- | -3.29 | 1.09 | 20.10 | -- | 16.76 | -- |
Aarey Drugs and Pharmaceuticals Ltd | 4.72bn | 65.28m | 1.77bn | 0.00 | 24.80 | -- | 21.38 | 0.3751 | 2.51 | 2.51 | 179.80 | -- | -- | -- | -- | -- | -- | 2.30 | -- | 5.01 | 2.99 | 3.58 | 1.38 | 1.40 | -- | 0.5731 | -- | -- | -5.57 | 2.21 | 24.20 | -6.46 | -10.07 | -- |